Inventor
Jeff Pudlo
Inventor
Burlingame, CA, US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Hprimary
C07HSugars43%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms39%
C12NMicroorganisms or enzymes13%
Y02PClimate change mitigation technologies in the production or processing of goods4%
PatentTitleYear
7,057,027'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20066,962,783'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20056,875,593'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20056,683,166'Modified internucleoside linkages (ii)'20046,410,702'Modified internucleoside linkages (II)'20026,380,368'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20025,830,653'Methods of using oligomers containing modified pyrimidines'19985,817,781'Modified internucleoside linkages (II)'19985,792,608'Nuclease stable and binding competent oligomers and methods for their use'19985,645,985'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–1998Patents assigned to GILEAD SCIENCES INC (4)· patent assignee history
1997–2006Based in Burlingame, CA, US· patent location history
2002–2006Patents assigned to ISIS PHARMACEUTICALS INC (6)· patent assignee history
2004Based in Redwood City, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ISIS PHARMACEUTICALS INC | 6 | 2002–2006 |
| GILEAD SCIENCES INC | 4 | 1997–1998 |
Locations
| Location | Patents | Span |
|---|---|---|
| Burlingame, California, US | 9 | 1997–2006 |
| Redwood City, California, US | 1 | 2004 |